Description: TherapeuticsMD, Inc. operates as a women's healthcare product company in the United States. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter, vitamins, and cosmetics. It offers prenatal vitamins, vegan docosahexaenoic acid, iron supplements, Vitamin D supplements, natural menopause relief products, and scar tissue and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy and pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to healthcare providers, as well as directly through its Website to consumers. The company was founded in 2008 and is based in Boca Raton, Florida.
Home Page: www.therapeuticsmd.com
TXMD Technical Analysis
951 Yamato Road
Boca Raton,
FL
33431
United States
Phone:
561 961 1900
Officers
| Name | Title |
|---|---|
| Governor Thomas G. Thompson | Exec. Chairman |
| Mr. Hugh O'Dowd M.B.A. | Pres & Director |
| Mr. Robert G. Finizio | Co-Founder |
| Mr. Marlan D. Walker J.D. | Gen. Counsel & Secretay |
| Dr. Brian A. Bernick F.A.C.O.G., M.D. | Co-Founder,Co-CEO & Chief Medical Officer |
| Mr. Mark A. Glickman | Co-CEO & Chief Bus. Officer |
| Mr. Michael C. Donegan | Interim CFO, Chief Accounting Officer and Principal Financial & Accounting Officer |
| Ms. Daniella Silva | Chief Compliance Officer |
| Mr. Benjamin Foulk | VP of HR |
| Mr. Mitchell L. Krassan | Exec. VP and Chief Strategy & Performance Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 2.291 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 40.7475 |
| Price-to-Sales TTM: | 0.7174 |
| IPO Date: | 2003-12-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 416 |